Panagora Asset Management Inc Haemonetics Corp Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Panagora Asset Management Inc holds 33,805 shares of HAE stock, worth $2.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

33,805

Previous 33,557 0.74%

Holding current value

$2.78 Million

Previous $2.78 Million 2.16%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$72.45 - $91.58 $17,967 - $22,711	248 Added 0.74%	33,805 $2.72 Million
Q2 2024 Jul 29, 2024	SELL	$81.24 - $97.37 $165,079 - $197,855	-2,032 Reduced 5.71%	33,557 $2.78 Million
Q1 2024 May 07, 2024	SELL	$71.24 - $85.35 $439,978 - $527,121	-6,176 Reduced 14.79%	35,589 $3.04 Million
Q4 2023 Feb 08, 2024	SELL	$80.59 - $92.61 $82,362 - $94,647	-1,022 Reduced 2.39%	41,765 $3.57 Million
Q3 2023 Oct 31, 2023	BUY	$82.56 - $93.49 $3.53 Million - $4 Million	42,787 New	42,787 $3.83 Million
Q1 2023 May 11, 2023	SELL	$72.75 - $90.6 $10.2 Million - $12.7 Million	-139,717 Reduced 70.27%	59,116 $4.89 Million
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $142,752 - $166,508	1,933 Added 0.98%	198,833 $15.6 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $1.16 Million - $1.44 Million	-18,353 Reduced 8.53%	196,900 $14.6 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $1 Million - $1.35 Million	-20,385 Reduced 8.65%	215,253 $14 Million
Q1 2022 May 12, 2022	BUY	$43.77 - $63.22 $537,977 - $777,037	12,291 Added 5.5%	235,638 $14.9 Million
Q4 2021 Feb 10, 2022	SELL	$49.55 - $74.59 $71,649 - $107,857	-1,446 Reduced 0.64%	223,347 $11.8 Million
Q3 2021 Nov 10, 2021	SELL	$57.6 - $70.59 $181,094 - $221,934	-3,144 Reduced 1.38%	224,793 $15.9 Million
Q2 2021 Aug 11, 2021	BUY	$51.81 - $118.56 $11.8 Million - $26.9 Million	226,874 Added 21342.8%	227,937 $15.2 Million
Q1 2021 May 12, 2021	SELL	$111.01 - $139.48 $387,979 - $487,482	-3,495 Reduced 76.68%	1,063 $118,000
Q4 2020 Feb 10, 2021	SELL	$88.75 - $119.95 $350,030 - $473,082	-3,944 Reduced 46.39%	4,558 $541,000
Q3 2020 Nov 13, 2020	SELL	$75.65 - $93.58 $945,625 - $1.17 Million	-12,500 Reduced 59.52%	8,502 $742,000
Q2 2020 Aug 12, 2020	SELL	$84.96 - $118.91 $4.19 Million - $5.86 Million	-49,308 Reduced 70.13%	21,002 $1.88 Million
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $423,663 - $694,252	5,699 Added 8.82%	70,310 $7.01 Million
Q4 2019 Feb 12, 2020	SELL	$114.37 - $129.46 $2.61 Million - $2.96 Million	-22,846 Reduced 26.12%	64,611 $7.42 Million
Q3 2019 Nov 12, 2019	SELL	$117.16 - $138.52 $21.5 Million - $25.5 Million	-183,836 Reduced 67.76%	87,457 $11 Million
Q2 2019 Aug 09, 2019	SELL	$81.74 - $120.34 $20.3 Million - $29.9 Million	-248,616 Reduced 47.82%	271,293 $32.6 Million
Q1 2019 May 15, 2019	SELL	$83.25 - $102.12 $10.3 Million - $12.6 Million	-123,594 Reduced 19.21%	519,909 $45.5 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $5.38 Million - $6.92 Million	-59,323 Reduced 8.44%	643,503 $64.4 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $2.86 Million - $3.65 Million	-31,846 Reduced 4.33%	702,826 $80.5 Million
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $4.17 Million - $5.58 Million	-58,318 Reduced 7.35%	734,672 $65.9 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $491,649 - $602,497	8,097 Added 1.03%	792,990 $58 Million
Q4 2017 Feb 14, 2018	BUY	$44.96 - $58.99 $3.78 Million - $4.96 Million	84,027 Added 11.99%	784,893 $45.6 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $28.3 Million - $31.4 Million	700,866	700,866 $31.4 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.22B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Haemonetics Corp Transaction History